Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Lease Agreements (Tables)

3 Months Ended

Mar. 31, 2017

The changes in the liability related to the sublease agreement for the three months ended March 31, 2017 were as follows (in thousands):


Balance at January 1, 2017	$	3,460
Increase in deferred liability		495
Accretion of deferred liability		59
Amortization of deferred liability		(887)
Balance at March 31, 2017	$	3,127